MedPath

WYOST

WYOST

Approved
DIN Number

02545764

Drug Class

Human

Market Date

Jun 26, 2024

Company
HC

Sandoz Canada, Inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02545764
AIG Number0152691002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
M05BX04 DENOSUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification90:16.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

DENOSUMABActive
Strength: 120 MG / 1.7 ML
Monograph: DENOSUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.